申请人:Nanjing Allgen Pharma Co. Ltd.
公开号:US20150011530A1
公开(公告)日:2015-01-08
The present document describes novel molecules having protein tyrosine kinase inhibitory activity, and methods of synthesizing and using such compounds. More specifically, the present document describes compound of Formula (A): (Formula (A)) or a pharmaceutically acceptable salt, hydrate or solvate thereof, and methods of synthesizing and using such compounds.
本文件描述了具有蛋白酪氨酸激酶抑制活性的新型分子,以及合成和使用这些化合物的方法。更具体地,本文件描述了式(A)的化合物:(式(A))或其药学上可接受的盐,水合物或溶剂化物,以及合成和使用这些化合物的方法。